Dr Scott Wheelwright
Scott M. Wheelwright, PhD, is cofounder and principal consultant at Complya Asia, a consulting firm located in China that supports companies in Asia with Quality Assurance and cGMP compliance. Complya provides boots on the ground for companies running projects in Asia, including sourcing of drug substance, API, and testing. Complya also provides audits of vendors providing GLP and GMP services. We help clients select someone they can trust with their critical development and manufacturing activities. Dr. Wheelwright served as the founding COO for Innovent, a biopharmaceutical company in China and is founder and president of Strategic Manufacturing Worldwide, Inc., a consulting firm that provides business and technical expertise to biotech and related industries. Dr. Wheelwright has 30 years of hands on expertise quality assurance, regulatory, manufacturing and process development. He has directly participated in developing oncology, infectious disease, cardiovascular, wound healing, angiogenesis, vaccine and diagnostic products. Dr. Wheelwright has been an executive officer in several biotech startups, and has supervised the areas of manufacturing, process development, compliance, quality assurance, quality control, validation, engineering and facilities. He has led the development of several products that are now on the market and has led the construction of multiple manufacturing facilities that meet cGMP requirements. His corporate experience includes Abbott, Chiron (now Novartis) and Scios (now J&J). Dr. Wheelwright obtained his PhD degree in chemical engineering from the University of California at Berkeley and performed post-doctoral studies in biophysics at the Max Planck Institute in Germany. He is the author of a book on protein purification and has published many papers on process design, manufacturing, and compliance for pharmaceuticals and biologics.